vs
La Rosa Holdings Corp.（LRHC）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
La Rosa Holdings Corp.的季度营收约是SUTRO BIOPHARMA, INC.的1.7倍（$20.2M vs $11.6M），La Rosa Holdings Corp.同比增速更快（3.2% vs -21.4%），过去两年La Rosa Holdings Corp.的营收复合增速更高（72.5% vs -5.4%）
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
LRHC vs STRO — 直观对比
营收规模更大
LRHC
是对方的1.7倍
$11.6M
营收增速更快
LRHC
高出24.5%
-21.4%
两年增速更快
LRHC
近两年复合增速
-5.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.2M | $11.6M |
| 净利润 | $-5.5M | — |
| 毛利率 | 8.4% | — |
| 营业利润率 | -24.7% | — |
| 净利率 | -27.4% | — |
| 营收同比 | 3.2% | -21.4% |
| 净利润同比 | -125.7% | 35.4% |
| 每股收益（稀释后） | $-5.44 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LRHCSTRO
| Q4 25 | — | $11.6M | ||
| Q3 25 | $20.2M | $9.7M | ||
| Q2 25 | $23.2M | $63.7M | ||
| Q1 25 | $17.5M | $17.4M | ||
| Q4 24 | $17.7M | $14.8M | ||
| Q3 24 | $19.6M | $8.5M | ||
| Q2 24 | $19.1M | $25.7M | ||
| Q1 24 | $13.1M | $13.0M |
净利润LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | $-5.5M | $-56.9M | ||
| Q2 25 | $78.4M | $-11.5M | ||
| Q1 25 | $-95.7M | $-76.0M | ||
| Q4 24 | $-5.1M | $-72.4M | ||
| Q3 24 | $-2.5M | $-48.8M | ||
| Q2 24 | $-2.3M | $-48.0M | ||
| Q1 24 | $-4.6M | $-58.2M |
毛利率LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 8.9% | — |
营业利润率LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | -24.7% | -499.9% | ||
| Q2 25 | -10.6% | -5.2% | ||
| Q1 25 | -26.7% | -393.8% | ||
| Q4 24 | -17.1% | -440.7% | ||
| Q3 24 | -8.9% | -797.2% | ||
| Q2 24 | -9.7% | -189.4% | ||
| Q1 24 | -35.0% | -435.0% |
净利率LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | -27.4% | -586.6% | ||
| Q2 25 | 337.8% | -18.0% | ||
| Q1 25 | -546.5% | -436.6% | ||
| Q4 24 | -28.7% | -489.2% | ||
| Q3 24 | -12.5% | -572.6% | ||
| Q2 24 | -12.2% | -186.8% | ||
| Q1 24 | -35.1% | -447.5% |
每股收益（稀释后）LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | $-5.44 | $-0.67 | ||
| Q2 25 | $15.25 | $-0.14 | ||
| Q1 25 | $-5.86 | $-0.91 | ||
| Q4 24 | $28.54 | $-27.63 | ||
| Q3 24 | $-16.49 | $-0.59 | ||
| Q2 24 | $-12.49 | $-0.59 | ||
| Q1 24 | $-0.35 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $141.4M |
| 总债务越低越好 | $642.8K | — |
| 股东权益账面价值 | $1.6M | $-132.5M |
| 总资产 | $21.7M | $173.8M |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
现金及短期投资LRHCSTRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | $4.0M | $167.6M | ||
| Q2 25 | $5.1M | $205.1M | ||
| Q1 25 | $2.9M | $249.0M | ||
| Q4 24 | $1.4M | $316.9M | ||
| Q3 24 | $1.8M | $388.3M | ||
| Q2 24 | $1.6M | $375.6M | ||
| Q1 24 | $1.1M | $267.6M |
总债务LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | $642.8K | — | ||
| Q2 25 | $644.3K | — | ||
| Q1 25 | $645.9K | — | ||
| Q4 24 | $647.6K | — | ||
| Q3 24 | $649.2K | — | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | — |
股东权益LRHCSTRO
| Q4 25 | — | $-132.5M | ||
| Q3 25 | $1.6M | $-87.3M | ||
| Q2 25 | $3.4M | $-32.1M | ||
| Q1 25 | $-87.5M | $-25.8M | ||
| Q4 24 | $2.6M | $44.6M | ||
| Q3 24 | $5.0M | $111.2M | ||
| Q2 24 | $4.7M | $152.2M | ||
| Q1 24 | $5.6M | $98.0M |
总资产LRHCSTRO
| Q4 25 | — | $173.8M | ||
| Q3 25 | $21.7M | $209.7M | ||
| Q2 25 | $22.9M | $262.4M | ||
| Q1 25 | $21.0M | $321.4M | ||
| Q4 24 | $19.4M | $387.2M | ||
| Q3 24 | $19.7M | $451.8M | ||
| Q2 24 | $18.7M | $489.0M | ||
| Q1 24 | $16.3M | $403.4M |
负债/权益比LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LRHCSTRO
| Q4 25 | — | $-177.2M | ||
| Q3 25 | $-1.3M | $-38.2M | ||
| Q2 25 | $-1.4M | $-44.7M | ||
| Q1 25 | $-3.5M | $-67.9M | ||
| Q4 24 | $-1.1M | $-71.7M | ||
| Q3 24 | $-591.6K | $-64.5M | ||
| Q2 24 | $-803.1K | $9.5M | ||
| Q1 24 | $-538.3K | $-64.7M |
现金转化率LRHCSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
STRO
暂无分部数据
